Female pattern hair loss
Conditions
Interventions
A randomized, controlled, blind-eyed, parallel, monocentric, randomized, 24-week follow-up clinical trial involving 60 patients will be conducted. After signing the consent form (Annex 2) patients wil
Drug
Sponsors
Faculdade Medicina da Universidade Estadual Paulista - UNESP
Faculdade Medicina da Universidade Estadual Paulista - UNESP
Eligibility
Sex/Gender
Female
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: Patients with female pattern hair loss; age between 20 and 55 years
Exclusion criteria
Exclusion criteria: Patients who had been treated for hair loss in the last 6 months, patients with hipertension, heart and kidney disease, patients with other causes of hair loss tha female pattern hair loss, patients in childbearing age who not using contraception;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased of hair count in an area of 2 cm² that will be clipped (leaving hairs with a length of 1 mm) in the parietal region (at the point of intersection of the sagittal midline with the line passing through pre-auricular region). Dermoscopic photo will be performed with Trichoscan® equipment. Using ImageJ® software, the area count will be counted before the start of treatment and after 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactPaulo Ramos
Faculdade Medicina da Universidade Estadual Paulista - UNESP
Outcome results
None listed